Synopsis: JBM Auto, Neuland Laboratories, Cemindia Projects, Grasim Industries, and Zydus Lifesciences have formed a golden crossover pattern, indicating improving momentum and potential bullish sentiment among investors.
A golden crossover is a widely followed technical signal that indicates improving momentum in a stock. It is generally considered a bullish sign, suggesting that the stock may continue to move higher as market sentiment becomes more positive.
This pattern occurs when the 50-day moving average crosses above the 200-day moving average. The crossover shows that the stock’s recent price performance is stronger than its long-term trend, often attracting investor attention and increasing buying activity. Here are a few Nifty 500 stocks with a golden crossover
JBM Auto Limited
JBM Auto Limited is an Indian automobile and electric mobility company, part of the JBM Group. It operates across auto components, buses, electric vehicles, EV charging and related clean-mobility solutions, with a growing presence in India’s electric bus market.
The golden crossover took place on June 3, 2026, at a price of Rs. 614.72 with decent volumes of 1.35 million shares. The stock is currently trading at Rs. 692.80 in Thursday’s session, reflecting a 3.52 percent increase in the intraday trade.
Neuland Laboratories Limited
Neuland Laboratories Limited is an Indian publicly listed pharmaceutical company focused on manufacturing active pharmaceutical ingredients (APIs), advanced intermediates, and peptide APIs for global innovator and generic drug companies. It operates as a contract development and manufacturing organization (CDMO) with a strong specialization in complex, high-value APIs.
The golden crossover took place on June 1, 2026, at a price of Rs. 14,916.42 with decent volumes of 80.9k shares. The stock is currently trading at Rs. 16,860 in Thursday’s session, reflecting a 0.78 percent decrease in the intraday trade.
Cemindia Projects Limited
Cemindia Projects Limited is one of India’s leading engineering, procurement, and construction (EPC) companies, specializing in heavy civil infrastructure projects. Founded in 1978 and formerly known as ITD Cementation India Limited, the company has built a strong reputation over more than nine decades of engineering expertise and project execution. In 2025, the company was renamed Cemindia Projects Limited following its association with the Adani Group.
The golden crossover took place on June 2, 2026, at a price of Rs. 741.94 with decent volumes of 547.4k shares. The stock is currently trading at Rs. 1,127.30 in Thursday’s session, reflecting a 10 percent increase in the intraday trade.
Grasim Industries Limited
Grasim Industries Limited is a leading Indian diversified manufacturing company and the flagship of the Aditya Birla Group. Founded in 1947, it began as a textile manufacturer and has evolved into a global player in viscose fibers, chemicals, cement, financial services, and paints. It is one of India’s most valuable and sustainability-focused industrial conglomerates.
The golden crossover took place on May 29, 2026, at a price of Rs. 2,806.10 with strong volumes of 1.64 million shares. The stock is currently trading at Rs. 3,103.50 in Thursday’s session, reflecting a 0.06 percent increase in the intraday trade.
Zydus Lifesciences Limited
The golden crossover took place on June 3, 2026, at a price of Rs. 204.63 with decent volumes of 1.4 million shares. The stock is currently trading at Rs. 1,084.60 in Thursday’s session, reflecting a 0.74 percent decrease in the intraday trade.
Zydus Lifesciences Limited is an Indian multinational pharmaceutical and healthcare company headquartered in Ahmedabad, Gujarat. Formerly known as Cadila Healthcare Limited, it is among India’s leading drug manufacturers, engaged in research, development, manufacturing, and marketing of a wide range of pharmaceutical products and wellness solutions.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
